Device / Technology News

RSS

Premier, Horizon enter three-year national group purchasing contract

Horizon Software International, the leader in K-12 food service technology and online account management, has been awarded a three-year national group purchasing contract with the Premier healthcare alliance.

17 Jan 2012

Geisinger, InVivo to conduct injectable biocompatible hydrogel preclinical study for PNI

InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), and Geisinger Health System today announced a research collaboration to conduct a preclinical study using InVivo's injectable biocompatible hydrogel for the treatment of chronic pain caused by peripheral nerve compression.

17 Jan 2012

Dental Lab Products magazine recognizes Objet Eden260V 3D Printer as 2011 Readers' Choice

Objet Ltd., the innovation leader in 3D printing for rapid prototyping and additive manufacturing, today announced that the Objet Eden260V 3D Printer has been recognized as a 2011 "Readers' Choice" by subscribers to Dental Lab Products magazine.

17 Jan 2012

AAN neurologist receives prestigious award at Palatucci Advocacy Leadership Forum

The American Academy of Neurology(AAN) has named neurologist Constantine Moschonas, MD, of Scottsdale, Ariz., as the AAN Donald M. Palatucci Advocacy Leadership Forum Advocate of the Year. Moschonas received his award at the Palatucci Advocacy Leadership Forum on January 14, 2012, in Austin, Texas, for his outstanding work in raising awareness about brain diseases such as Alzheimer's disease, stroke, autism, Parkinson's disease and multiple sclerosis.

17 Jan 2012

Stallergenes chooses Magic Software's iBOLT integration platform

Magic Software Enterprises Ltd., a global provider of mobile and cloud-enabled application and business integration platforms, announced today that Stallergenes, a biopharmaceutical company and world leader in the treatment of severe allergic respiratory illnesses, has chosen Magic Software's iBOLT integration platform to integrate its various purchasing systems with its SAP ERP.

17 Jan 2012

No statistical difference between IO and IV infusion in therapeutic hypothermia

The results of a study conducted by Vidacare Corporation comparing whether Intraosseous (IO) vascular access may be used to infuse chilled saline as effectively as peripheral intravenous (IV) access to achieve therapeutic hypothermia found no statistical difference between the two routes.

17 Jan 2012

FRAX tool now available as version 3.5 in 18 languages

FRAX, which is available free online at http://www.shef.ac.uk/FRAX/, is being used by an increasing number of physicians around the world - the online version alone is used to calculate 10-year probability of fracture in approximately 2.8 million patients annually, with numbers growing steadily.

17 Jan 2012

Arm sling or cast use after injury may cause rapid brain shift

Using a sling or cast after injuring an arm may cause your brain to shift quickly to adjust, according to a study published in the January 17, 2012, print issue of Neurology-, the medical journal of the American Academy of Neurology.

17 Jan 2012

Traditional autopsy is still the gold standard in determining cause of death

TV crime shows like Bones and CSI are quick to explain each death by showing highly detailed scans and video images of victims' insides. Traditional autopsies, if shown at all, are at best in supporting roles to the high-tech equipment, and usually gloss over the sometimes physically grueling tasks of sawing through skin and bone.

17 Jan 2012

Nashville General Hospital at Meharry, Sectra announce multi-year agreement

Sectra announces its multi-year agreement with Nashville General Hospital at Meharry. Sectra's suite of web-based, integrated RIS/PACS solutions for radiology, breast imaging and orthopaedics will enable the hospital to automate workflow, speed image distribution and report turnaround to improve its service level to referring physicians and increase referring volume.

17 Jan 2012

Positive outcomes from Boston Scientific's Epic Stent trial on iliac artery disease

Boston Scientific Corporation reports nine-month clinical endpoint data from its ORION trial, demonstrating excellent outcomes for the Company's Epic Self-Expanding Nitinol Stent System in patients with iliac artery disease, a form of peripheral artery disease associated with severe leg pain caused by insufficient blood flow.

16 Jan 2012

AxoGen reports results from Avance Nerve Graft clinical study on PNI

AxoGen, Inc., an emerging regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today reported the publication of peer-reviewed clinical research conducted at twelve leading US surgical sites and led by the Buncke Clinic in San Francisco.

16 Jan 2012

ForSight VISION4 to receive first milestone payment for Lucentis drug delivery device

Genentech, a member of the Roche Group, today announced it will make its first milestone payment to ForSight VISION4, Inc. as part of an exclusive license agreement to develop the company's investigational drug delivery device, designed to provide sustained delivery of Lucentis (ranibizumab).

13 Jan 2012

Improving obstetric care with solar power

In the National Geographic News blog "Mobile Message," "a series of posts from FrontlineSMS about how mobile phones and appropriate technologies are being used throughout the world to improve, enrich, and empower billions of lives," Laura Stachel, an obstetrician-gynecologist and the co-founder and executive director of WE CARE Solar, writes about the "'Solar Suitcase,' a portable, rugged, complete solar electric kit packed with solar panels, a charge controller, batteries, medical LED lights, phone chargers, headlamps, and a fetal monitor."

13 Jan 2012

Agilux implements Thermo Watson LIMS for bioanalytical services

Agilux Laboratories, a provider of pharmaceutical and biotech services, today announced that it has completed the validation and implementation of the Thermo Watson Laboratory Information Management System (LIMS) for the company's bioanalytical services.

13 Jan 2012

Governors' agendas include Medicaid but not much on state insurance exchanges

Meanwhile, a Colorado legislator seeks to force the governor to ask for a waiver to change the Medicaid program.

13 Jan 2012

U.S. Army working to bring virtual health care to Albanian hospitals

The U.S. Army in a news article on its website reports on how it is working to "bring virtual health care to Albanian hospitals" through a telemedicine program that "aims to link different levels of health care to ensure a better functioning and sustainable system."

13 Jan 2012

IBM's non-contact, microfluidic, silicon probe minimizes patient discomfort

IBM scientists have developed a flexible, non-contact microfluidic probe made from silicon that can aid researchers and pathologists to investigate critical tissue samples accurately for drug discovery and disease diagnostics.

13 Jan 2012

NimbleGen Sequence Capture 385K array identifies gene mutations linked with hereditary hearing loss

Hereditary hearing loss is the most common sensory disorder in humans. A German research team led by Ingo Kurth from the Institute of Human Genetics at the University Hospital Jena, Germany, used a number of different methods, including Roche's NimbleGen Custom Sequence Capture 385K array to identify the gene mutated in the disease locus of the X-chromosome of a Spanish family with hereditary hearing loss.

13 Jan 2012

Smart injectable nanotherapeutics could improve treatment for Type I diabetes

A research collaboration between the Wyss Institute for Biologically Inspired Engineering at Harvard University and Children's Hospital Boston has developed "smart" injectable nanotherapeutics that can be programmed to selectively deliver drugs to the cells of the pancreas. Although this nanotechnology will need significant additional testing and development before being ready for clinical use, it could potentially improve treatment for Type I diabetes by increasing therapeutic efficacy and reducing side effects.

13 Jan 2012